在糖尿病患者中,电解质和糖化血红蛋白之间的关系与不良的抗糖尿病药物的坚持:一个横截面研究
Francis Lengeiya1, Scholastica Mathenge1, Patroba Ojola2
1Department of Medical Laboratory Sciences, Kenyatta University, Nairobi, Kenya.
The Pan African medical journal
|April 8, 2024
概括
这项研究发现,糖尿病药物的不良坚持与电解质失衡之间存在联系. 具体来说,较低的和水平与2型糖尿病患者的高糖血红素有显著的相关性.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 临床化学 临床化学
背景情况:
- 2型糖尿病 (T2DM) 的管理需要最佳的血糖控制.
- 药物坚持对于预防T2DM并发症至关重要.
- 电解质平衡对生理功能至关重要,但其与非坚持患者的血糖控制的联系还未得到充分研究.
研究的目的:
- 为了研究糖化血红蛋白 (HbA1c) 和电解质水平之间的关系.
- 专注于糖尿病患者表现出对抗糖尿病药物的不良坚持.
主要方法:
- 在肯尼亚桑布鲁县推医院进行了一项描述性的横截面研究.
- 纳入了72名具有较低依从度 (莫里斯基药物依从度-8分数<6) 的成人糖尿病患者.
- 使用卡尔·皮尔森相关性,分析了血液样本的HbA1c和关键电解质 (,,,,,,,,).
主要成果:
- 很大一部分 (58.3%) 的非坚持患者的HbA1c水平升高,表明血糖控制不佳.
- 在HbA1c和 (r=-0.2398,P≤0.05) 和 (r=-0.31369,P≤0.05) 之间发现了统计学上显著的负相关性.
- 对,,化物和与HbA1c观察到非显著的负相关性.
结论:
- 在T2DM患者中,糖化血红蛋白和电解质水平之间存在关系,这些患者药物坚持不佳.
- 血糖控制,如HbA1c所示,与该人群中的和水平显著相关.
- 进一步的研究可能会阐明这些电解质-血糖关联在非坚持糖尿病患者的临床影响.
相关概念视频
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
528
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
528
Diabetes: Management and Pharmacotherapy
275
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
275
Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154
Overview of Carbohydrate Metabolism
981
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
981


